BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 7961295)

  • 1. Comparative toxicity of oxidatively modified low-density lipoprotein and lysophosphatidylcholine in cultured vascular endothelial cells.
    Naito M; Yamada K; Hayashi T; Asai K; Yoshimine N; Iguchi A
    Heart Vessels; 1994; 9(4):183-7. PubMed ID: 7961295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of lectin-like oxidized LDL receptor by oxidized LDL and lysophosphatidylcholine in cultured endothelial cells.
    Aoyama T; Fujiwara H; Masaki T; Sawamura T
    J Mol Cell Cardiol; 1999 Dec; 31(12):2101-14. PubMed ID: 10640439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of endothelin-1 secretion by lysophosphatidylcholine in oxidized low density lipoprotein in cultured vascular endothelial cells.
    Jougasaki M; Kugiyama K; Saito Y; Nakao K; Imura H; Yasue H
    Circ Res; 1992 Sep; 71(3):614-9. PubMed ID: 1499109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative modification of low-density lipoproteins and the inhibition of relaxations mediated by endothelium-derived nitric oxide in rabbit aorta.
    Plane F; Bruckdorfer KR; Kerr P; Steuer A; Jacobs M
    Br J Pharmacol; 1992 Jan; 105(1):216-22. PubMed ID: 1596684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidized LDL suppresses NF-kappaB and overcomes protection from apoptosis in activated endothelial cells.
    Heermeier K; Leicht W; Palmetshofer A; Ullrich M; Wanner C; Galle J
    J Am Soc Nephrol; 2001 Mar; 12(3):456-463. PubMed ID: 11181793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysophosphatidylcholine is involved in the antigenicity of oxidized LDL.
    Wu R; Huang YH; Elinder LS; Frostegård J
    Arterioscler Thromb Vasc Biol; 1998 Apr; 18(4):626-30. PubMed ID: 9555869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effects of idebenone on vascular endothelial cells against toxicity induced by oxidatively modified low density lipoprotein.
    Naito M; Hayashi T; Yamada K; Asai K; Yoshimine N; Iguchi A
    Artery; 1993; 20(6):314-23. PubMed ID: 8010887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LOX-1 mediates lysophosphatidylcholine-induced oxidized LDL uptake in smooth muscle cells.
    Aoyama T; Chen M; Fujiwara H; Masaki T; Sawamura T
    FEBS Lett; 2000 Feb; 467(2-3):217-20. PubMed ID: 10675541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LPC in oxidized LDL elicits vasocontraction and inhibits endothelium- dependent relaxation.
    Murohara T; Kugiyama K; Ohgushi M; Sugiyama S; Ohta Y; Yasue H
    Am J Physiol; 1994 Dec; 267(6 Pt 2):H2441-9. PubMed ID: 7810742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxicity of oxidized low density lipoproteins for vascular smooth muscle cells and partial protection by antioxidants.
    Guyton JR; Lenz ML; Mathews B; Hughes H; Karsan D; Selinger E; Smith CV
    Atherosclerosis; 1995 Dec; 118(2):237-49. PubMed ID: 8770318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies against lysophosphatidylcholine and oxidized LDL in patients with SLE.
    Wu R; Svenungsson E; Gunnarsson I; Andersson B; Lundberg I; Schäfer Elinder L; Frostegård J
    Lupus; 1999; 8(2):142-50. PubMed ID: 10192509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of nonselective cation current by oxidized LDL and lysophosphatidylcholine and its inhibitory contribution to endothelial damage.
    Liang GH; Park S; Kim MY; Kim JA; Choi S; Suh SH
    Life Sci; 2010 May; 86(19-20):733-9. PubMed ID: 20226792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High density lipoprotein reverses inhibitory effect of oxidized low density lipoprotein on endothelium-dependent arterial relaxation.
    Matsuda Y; Hirata K; Inoue N; Suematsu M; Kawashima S; Akita H; Yokoyama M
    Circ Res; 1993 May; 72(5):1103-9. PubMed ID: 8477522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of intracellular iron in the toxicity of oxidized low density lipoprotein to cultured endothelial cells.
    Kuzuya M; Naito M; Yamada K; Funaki C; Hayashi T; Asai K; Kuzuya F
    Biochem Int; 1990 Nov; 22(3):567-73. PubMed ID: 2076112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of oxidized low-density lipoprotein-induced apoptosis in endothelial cells by nitric oxide. Peroxyl radical scavenging as an antiapoptotic mechanism.
    Kotamraju S; Hogg N; Joseph J; Keefer LK; Kalyanaraman B
    J Biol Chem; 2001 May; 276(20):17316-23. PubMed ID: 11278975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phospholipid hydrolysis of mildly oxidized LDL reduces their cytotoxicity to cultured endothelial cells. Potential protective role against atherogenesis.
    Schmitt A; Nègre-Salvayre A; Troly M; Valdiguié P; Salvayre R
    Biochim Biophys Acta; 1995 Jun; 1256(3):284-92. PubMed ID: 7786889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysophosphatidylcholine-induced cytotoxicity and protection by heparin in mouse brain bEND.3 endothelial cells.
    Tsai TY; Leong IL; Cheng KS; Shiao LR; Su TH; Wong KL; Chan P; Leung YM
    Fundam Clin Pharmacol; 2019 Feb; 33(1):52-62. PubMed ID: 29974515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A high concentration of melatonin inhibits in vitro LDL peroxidation but not oxidized LDL toxicity toward cultured endothelial cells.
    Walters-Laporte E; Furman C; Fouquet S; Martin-Nizard F; Lestavel S; Gozzo A; Lesieur D; Fruchart JC; Duriez P; Teissier E
    J Cardiovasc Pharmacol; 1998 Oct; 32(4):582-92. PubMed ID: 9781926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modified low density lipoprotein and its constituents augment cytokine-activated vascular cell adhesion molecule-1 gene expression in human vascular endothelial cells.
    Khan BV; Parthasarathy SS; Alexander RW; Medford RM
    J Clin Invest; 1995 Mar; 95(3):1262-70. PubMed ID: 7533787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysophosphatidylcholine (LPC) induces proinflammatory cytokines by a platelet-activating factor (PAF) receptor-dependent mechanism.
    Huang YH; Schäfer-Elinder L; Wu R; Claesson HE; Frostegård J
    Clin Exp Immunol; 1999 May; 116(2):326-31. PubMed ID: 10337026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.